Terms: = Bone cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
181 results:
1. C9orf10/Ossa regulates the bone metastasis of established lung adenocarcinoma cell subline H322L-BO4 in a mouse model.
Uekita T; Yagi R; Ichimura T; Sakai R
Genes Cells; 2024 Apr; 29(4):290-300. PubMed ID: 38339971
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
3. Exploration in the Mechanism of Ginsenoside Rg5 for the treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
4. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract] [Full Text] [Related]
5. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
6. E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
7. Traditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases.
Wang Y; Wang X; Su K; Yang Y
Curr Cancer Drug Targets; 2023; 23(10):751-763. PubMed ID: 37170983
[TBL] [Abstract] [Full Text] [Related]
8. An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.
Gunner CB; Azmoon P; Mantuano E; Das L; Zampieri C; Pizzo SV; Gonias SL
J Cell Biochem; 2023 May; 124(5):743-752. PubMed ID: 36947703
[TBL] [Abstract] [Full Text] [Related]
9. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.
Kamolphiwong R; Kanokwiroon K; Wongrin W; Chaiyawat P; Klangjorhor J; Settakorn J; Teeyakasem P; Sangphukieo A; Pruksakorn D
Gene; 2023 Mar; 856():147106. PubMed ID: 36513192
[TBL] [Abstract] [Full Text] [Related]
10. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells.
Huang TT; Chen CM; Lan YW; Lin SS; Choo KB; Chong KY
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499211
[TBL] [Abstract] [Full Text] [Related]
11. Research of the Active Components and Potential Mechanisms of Qingfei Gujin Decoction in the treatment of Osteosarcoma Based on Network Pharmacology and Molecular Docking Technology.
Yan Q; Yang J; Yao Y; Jia Z; Wang Y; Cheng M; Yan X; Xu Y
Comput Math Methods Med; 2022; 2022():7994425. PubMed ID: 36466554
[TBL] [Abstract] [Full Text] [Related]
12. Androgen receptor variant-7 regulation by tenascin-c induced src activation.
Thomas R; Jerome JM; Dang TD; Souto EP; Mallam JN; Rowley DR
Cell Commun Signal; 2022 Aug; 20(1):119. PubMed ID: 35948987
[TBL] [Abstract] [Full Text] [Related]
13. Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.
Wenta T; Schmidt A; Zhang Q; Devarajan R; Singh P; Yang X; Ahtikoski A; Vaarala M; Wei GH; Manninen A
Oncogene; 2022 Jul; 41(30):3804-3820. PubMed ID: 35773413
[TBL] [Abstract] [Full Text] [Related]
14. Synergistic effect of growth factor receptor-bound protein 2/epidermal growth factor receptor dual-targeting peptide inhibitor and salinomycin on osteosarcoma.
Yu Z; Xu Y; Du L; Zhang F; Shao M; Xie L; Cai G; Lyu F
J Cancer Res Ther; 2022 Apr; 18(2):352-361. PubMed ID: 35645100
[TBL] [Abstract] [Full Text] [Related]
15. A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia.
Kasner MT; Halloran MB; Pan J; Ritchie EK; Fetterly GJ; Kramer D; Hangauer DG; Thompson JE
Invest New Drugs; 2022 Aug; 40(4):773-781. PubMed ID: 35579731
[TBL] [Abstract] [Full Text] [Related]
16. Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α
Tai HC; Wang SW; Swain S; Lin LW; Tsai HC; Liu SC; Wu HC; Guo JH; Liu CL; Lai YW; Lin TH; Yang SF; Tang CH
J Pineal Res; 2022 Apr; 72(3):e12793. PubMed ID: 35174530
[TBL] [Abstract] [Full Text] [Related]
17. Signal-transducing adaptor protein-1 and protein-2 in hematopoiesis and diseases.
Ichii M; Oritani K; Toda J; Hosen N; Matsuda T; Kanakura Y
Exp Hematol; 2022 Jan; 105():10-17. PubMed ID: 34780812
[TBL] [Abstract] [Full Text] [Related]
18. A Conformation Selective Mode of Inhibiting src Improves Drug Efficacy and Tolerability.
Temps C; Lietha D; Webb ER; Li XF; Dawson JC; Muir M; Macleod KG; Valero T; Munro AF; Contreras-Montoya R; Luque-Ortega JR; Fraser C; Beetham H; Schoenherr C; Lopalco M; Arends MJ; Frame MC; Qian BZ; Brunton VG; Carragher NO; Unciti-Broceta A
Cancer Res; 2021 Nov; 81(21):5438-5450. PubMed ID: 34417202
[TBL] [Abstract] [Full Text] [Related]
19. Successful treatment using targeted therapy, radiotherapy, and intrathecal chemotherapy in a patient with leptomeningeal metastasis with an epidermal growth factor receptor exon 20 insertion mutation: a case report.
Ma Y; Liu H; Zhang M; Liu B; Ding Q; Zhang L; Guo L; Liu M
Ann Palliat Med; 2022 Apr; 11(4):1533-1541. PubMed ID: 34263612
[TBL] [Abstract] [Full Text] [Related]
20. The nonreceptor protein tyrosine kinase src participates in every step of cancer-induced bone pain.
Li Y; Bao Y; Zheng H; Qin Y; Hua B
Biomed Pharmacother; 2021 Sep; 141():111822. PubMed ID: 34147901
[TBL] [Abstract] [Full Text] [Related]
[Next]
